TransMedics to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026

Core Viewpoint - TransMedics Group, Inc. will release its financial results for the fourth quarter and full year 2025 on February 24, 2026, after market close, highlighting its ongoing commitment to transforming organ transplant therapy [1] Company Overview - TransMedics is a medical technology company focused on organ transplant therapy for patients with end-stage lung, heart, and liver failure [1] - The company is recognized as the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation [1] - TransMedics aims to address the unmet need for more and better organs for transplantation through its developed technologies that preserve organ quality and assess organ viability [1] Financial Results Announcement - The financial results will be announced after market close on February 24, 2026, with a conference call scheduled for 4:30 p.m. ET / 1:30 p.m. PT [1] - Investors can participate in the conference call by dialing specific numbers for domestic and international callers [1] - A live and archived webcast of the event will be available on the company's investor relations website [1]